Anoikis resistance has been reported to be caused by abnormal expression of certain genes (such as TrkB, CTNNB1 and HSP70A1A) or pathways (such as the Wnt/β-catenin pathway), and enhance the metastatic ability of cancer cells 29, 36-38. Here, NTRK2 is linked to cancer.